Rosiglitazone improves postprandial glycemia and markers of endothelial function in patients with type 2 diabetes

被引:0
|
作者
Agrawal, A
Chen, HZ
Yan, Y
Mather, R
Albertini, JP
Valensi, P
Hanefeld, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
372
引用
收藏
页码:A92 / A92
页数:1
相关论文
共 50 条
  • [1] Rosiglitazone improves postprandial glycaemia and markers of endothelial function in patients with Type 2 diabetes
    Agrawal, A
    Chen, H
    Yan, Y
    Mather, R
    Albertini, JP
    Valensi, P
    Hanefeld, M
    DIABETOLOGIA, 2002, 45 : A251 - A251
  • [2] Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin
    Naka, Katerina K.
    Papathanassiou, Katerina
    Bechlioulis, Aris
    Pappas, Konstantinos
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Papafaklis, Michail I.
    Kostoula, Aggeliki
    Vezyraki, Patra
    Makriyiannis, Demetrios
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (03): : 195 - 201
  • [3] Rosiglitazone improves postprandially endothelial dysfunction in patients with type 2 diabetes
    Ioannidis, G.
    Pastromas, S.
    Koulouris, S.
    Sakellariou, D.
    Tousoulis, D.
    Zakopoulos, N.
    Nikon, A.
    Stefanadis, C.
    Manolis, A.
    DIABETOLOGIA, 2007, 50 : S483 - S483
  • [4] Rosiglitazone directly improves endothelial function in type 2 diabetic patients
    Natali, A
    Baldeweg, S
    Toschi, E
    Barbaro, D
    Capaldo, B
    Yudkin, J
    Ferrannini, E
    DIABETES, 2002, 51 : A142 - A142
  • [5] The insulin sensitizer rosiglitazone improves endothelial function in insulin-dependent patients with type 2 diabetes
    Naka, K.
    Papathanassiou, K.
    Kazakos, N.
    Bechlioulis, A.
    Pappas, K.
    Liveris, K.
    Makriyiannis, D.
    Tsatsoulis, A.
    Michalis, L. K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 466 - 466
  • [6] Do the patients with diabetes of type 2 measure their postprandial glycemia?
    Brindisi, MC
    Mueller, S
    Hanh, J
    Chiasson, JL
    Rabasa-Lhoret, R
    DIABETES & METABOLISM, 2006, 32 : S93 - S93
  • [7] P.050 The Insulin Sensitizer Rosiglitazone Improves Endothelial Function in Patients with Type 2 Diabetes on Insulin
    K. Papathanassiou
    K. K. Naka
    N. Kazakos
    K. Pappas
    K. Liveris
    D. Makriyiannis
    A. Tsatsoulis
    L. K. Michalis
    Artery Research, 2006, 1 (Suppl 1) : S39 - S39
  • [8] Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus
    Kelly, Aaron S.
    Thelen, Andrea M.
    Kaiser, Daniel R.
    Gonzalez-Campoy, J. Michael
    Bank, Alan J.
    VASCULAR MEDICINE, 2007, 12 (04) : 311 - 318
  • [9] Raspberries modulate postprandial glycemia and markers of lipid oxidation and inflammation in type 2 diabetes
    Schell, Jace
    Betts, Nancy
    Basu, Arpita
    FASEB JOURNAL, 2017, 31
  • [10] Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes
    Van Wijk, JPH
    De Koning, EJP
    Cabezas, MC
    Rabelink, TJ
    DIABETES CARE, 2005, 28 (04) : 844 - 849